afya20200522_6k.htm - Generated by SEC Publisher for SEC Filing

 

 

 

 

UNITED STATES 

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May, 2020

 

 

 Commission File Number: 001-38992

 

Afya Limited

 

(Exact name of registrant as specified in its charter)

 

Alameda Oscar Niemeyer, No. 119, Salas 502, 504, 1,501 and 1,503

 

Vila da Serra, Nova Lima, Minas Gerais

 

Brazil

 

+55 (31) 3515 7550

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

X

  Form 40-F  

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes     No

X

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes     No

X

 

 

 

 

 

 

TABLE OF CONTENTS

 

EXHIBIT  
99.1 Press release dated May 22, 2020 - RI Press Release Coronavirus.


 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    Afya Limited
     
     
      By: /s/ Virgilio Deloy Capobianco Gibbon
        Name: Virgilio Deloy Capobianco Gibbon
        Title: Chief Executive Officer

Date: May 22, 2020

 

 

 

 

exhibit99_1.htm - Generated by SEC Publisher for SEC Filing  

Afya Limited Provides Business Update Relating to COVID-19 Outbreak

 

 

May 22, 2020 – Afya Limited, or Afya (Nasdaq: AFYA), in order to provide shareholders and the market an update regarding the development of the ongoing COVID-19 pandemic and its impact on business, announces the following:

 

As previously disclosed to the market on March 17, 2020, we managed to rapidly adapt our business to these unusual times, and although there has been an interruption of our on-campus activities, a significant portion of our non-practical educational activities are being successfully offered to our students through our online platform (rather than on-site) and we have received positive feedback from students, professors and physicians with respect to their digital experience.

Regarding the offering of practical classes, we already resumed to provide in-hospital internships for the 5th and 6th year students, which is the highest portion of our practical curriculum. We expect that some practical educational activities (particularly for students in the 1st. to 4th. years) will have to be replaced during the second half of 2020 postponing our revenue recognition proportionally. Those effects were already considered in our first semester Net Revenue guidance range.

Since we continue to offer our  high quality education to our students through our platform and practical activities for the 5th and 6th year, through the same professors, staff and suppliers, we remain regularly charging our standard monthly tuitions fees.  We are also not seeing any impact on the payment delinquency rate of our students, as of today, the accumulated ratio for 2020 is improved, when compared to same period in 2019. Finally, we do not have any current legal decision seeking the establishment of temporary discounts in the monthly tuition fees we charge our customers as a result of the COVID-19 pandemic.

We are committed to deliver the best quality service, minimizing the impact to our students, employees and our local communities during this crisis. Accordingly, we continue to support our students providing special payment conditions for families impacted by the economic crisis; we have released temporary access to our digital platform – MedCel – free of charge for other medical education institutions and have donated masks, gloves and other safety equipment to health departments and hospitals to the 13 cities where Afya’s medical courses are located.

While we are quite aware of the uncertainties created by COVID-19, we remain confident in our strategy, in the financial robustness of our business and in Afya’s contribution of high quality medical professionals who will help our society to overcome COVID-19 and other future challenges.

About Afya

 

Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners from the moment they join us as medical students through their medical residency preparation, graduation program, and continuing medical education activities.

 

Contact: Investor Relations: ir@afya.com.br